F-group (family)
131.1.1.1 PDEase_I
Ligands and drugs
2,234
Member domains
2,028
with ligand contacts (≤ 4 Å)
90.8% of members
1,972
with DrugDomain annotations
88.3% of members
529
with a DrugBank compound
23.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 131.1.1.1 belongs to X-group 131 PDEase-like, which binds 9.4 ligand superclasses per 20 proteins, broader than 88% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB07954 | IBM | 3-isobutyl-1-methyl-7H-xanthine | 43 |
| DB00536 | GAI | Guanidine | 38 |
| DB04149 | ROL | (R)-Rolipram | 22 |
| DB00131 | AMP | Adenosine phosphate | 18 |
| DB02918 | ZAR | Zardaverine | 14 |
| DB00203 | VIA | Sildenafil | 10 |
| DB01656 | ROF | Roflumilast | 8 |
| DB01791 | PIL | Piclamilast | 8 |
| DB04447 | DTT | 1,4-Dithiothreitol | 8 |
| DB00862 | VDN | Vardenafil | 7 |
| DB08299 | NPV | 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid | 7 |
| DB08811 | JPU | Tofisopam | 7 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 6 |
| DB02315 | PCG | Cyclic GMP | 6 |
| DB02527 | CMP | Cyclic adenosine monophosphate | 5 |
| DB05266 | — | Ibudilast | 5 |
| DB08387 | PF9 | Mardepodect | 5 |
| DB00277 | — | Theophylline | 4 |
| DB00651 | — | — | 4 |
| DB00820 | CIA | Tadalafil | 4 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 1,924 |
| MGmetal | MAGNESIUM ION | 1,892 |
| IBM | 3-ISOBUTYL-1-METHYLXANTHINE | 46 |
| NImetal | NICKEL (II) ION | 40 |
| GAI | GUANIDINE | 38 |
| CL | CHLORIDE ION | 28 |
| MNmetal | MANGANESE (II) ION | 28 |
| ROL | ROLIPRAM | 22 |
| PRmetal | PRASEODYMIUM ION | 17 |
| AMP | ADENOSINE MONOPHOSPHATE | 16 |
| ZAR | 6-(4-DIFLUOROMETHOXY-3-METHOXY-PHENYL)-2H-PYRIDAZIN-3-ONE | 14 |
| CAmetal | CALCIUM ION | 10 |
| VIA | 5-{2-ETHOXY-5-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-1-METHYL-3-PROPYL-1H,6H,7H-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE | 10 |
| X5M | (4~{R})-3-[4-(diethylamino)-3-[oxidanyl(oxidanylidene)-$l^{4}-azanyl]phenyl]-4-methyl-4,5-dihydro-1~{H}-pyridazin-6-one | 10 |
| 5GP | GUANOSINE-5'-MONOPHOSPHATE | 9 |
| NAmetal | SODIUM ION | 9 |
| 6PT | 4-[(5-acetyl-2-ethyl-3-oxo-6-phenyl-2,3-dihydropyridazin-4-yl)amino]benzoic acid | 8 |
| 7OJ | (3-bromo-4-fluorophenyl)[(5S)-3,3-difluoro-5-(5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperidin-1-yl]methanone | 8 |
| ARS | ARSENIC | 8 |
| D71 | 1-(3-nitrophenyl)-3-(pyridin-4-ylmethyl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione | 8 |